
Sign up to save your podcasts
Or


The trial of Theranos founder Elizabeth Holmes is dominating Silicon Valley headlines at the moment, but the real story is in how the company built and profited from its IP portfolio.
This week on Novel & Non-Obvious, Yoriko examines the blood testing company's patent portfolio and how it both propped up the company and led to its downfall.
By Yoriko MoritaThe trial of Theranos founder Elizabeth Holmes is dominating Silicon Valley headlines at the moment, but the real story is in how the company built and profited from its IP portfolio.
This week on Novel & Non-Obvious, Yoriko examines the blood testing company's patent portfolio and how it both propped up the company and led to its downfall.